MétaCan
Menu
Back to cohort

Standardizing health outcomes for people with rheumatoid arthritis receiving disease modifying drug therapy: A rapid review of patient-decision aids and preference studies to inform the development of OMERACT Health Outcome Descriptors

2025· review· en· W4411049871 on OpenAlexaff
NAOMI RASKIN, M. Hiligsmann, Ann Rebutoc, Nick Bansback, Annelies Boonen, Rachelle Buchbinder, Marie Falahee, Liana Fraenkel, Deborah A. Marshall, Lara Maxwell, Robby Nieuwlaat, Laurie Proulx, Pakeezah Saadat, Beverley Shea, Peter Tugwell, Wojtek Wiercioch, Dorcas Beaton, P. Scott Richards, Holger J. Schünemann, Francis Guillemin, Glen Hazlewood

Bibliographic record

VenueSeminars in Arthritis and Rheumatism · 2025
Typereview
Languageen
FieldMedicine
TopicRheumatoid Arthritis Research and Therapies
Canadian institutionsUniversity of OttawaBruyèreUniversity of TorontoMcMaster UniversityInstitute for Work & HealthOttawa HospitalResearch CanadaCanadian Arthritis Patient AllianceArthritis Research Centre of CanadaUniversity of Calgary
FundersNovartisAstellas Pharma US
KeywordsMedicineRheumatoid arthritisPreferenceDiseaseDecision aidsPhysical therapyAlternative medicineDrugArthritisFamily medicineIntensive care medicineInternal medicinePsychiatryPathology

Abstract

fetched live from OpenAlex

BACKGROUND: Interest in standardizing descriptions of health outcomes is increasing. In a Health Outcome Descriptor (HOD), outcomes are systematically described covering four domains: Symptoms, Time horizon, Testing and Treatment, and Consequences. Given the lack of HODs for Rheumatoid Arthritis (RA), the aim of this study was to review published RA outcome descriptions and map them to the HOD framework. METHODS: We conducted a rapid review of patient-decision aids (PtDAs) and patient preference studies to assess how seven RA outcomes have been described in English to patients. These outcomes were selected by author consensus, from a living systematic review of RA drug therapy. After data extraction and a thematic content analysis, a narrative summary for each outcome was provided. RESULTS: We included 11 PtDAs and 27 patient preference studies. Overall, the descriptions of the same health outcome varied widely across studies. Adverse events (AEs) were described in most cases (N = 26/38). For both PtDAs and preference studies, few provided a description for patient-important outcomes like remission (N = 2/11 and N = 1/27 respectively) and pain (N = 2/11 and N = 6/27 respectively). From an HOD perspective, the descriptions focused primarily on symptoms patients may experience (94 %), and less on the other domains (18-38 %). CONCLUSION: There is wide variability in the content of the published RA outcome descriptions, as well as a lack of descriptions regarding common patient-important outcomes. As this study provides a detailed overview of existing descriptions, it may inform future development of HODs for RA.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.141
metaresearch head score (Gemma)0.331
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Systematic review · Consensus signal: Systematic review
GenreCandidate signal: Review · Consensus signal: Review
Teacher disagreement score0.141
Threshold uncertainty score0.745

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.1410.331
Meta-epidemiology (narrow)0.0010.001
Meta-epidemiology (broad)0.0060.008
Bibliometrics0.0320.023
Science and technology studies0.0010.002
Scholarly communication0.0060.008
Open science0.0030.005
Research integrity0.0020.002
Insufficient payload (model declined to judge)0.0030.000

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.062
GPT teacher head0.375
Teacher spread0.312 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designSystematic review
Domainnot available
GenreReview

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations0
Published2025
Admission routes1
Has abstractyes

Explore more

Same venueSeminars in Arthritis and RheumatismSame topicRheumatoid Arthritis Research and TherapiesFrench-language works237,207